LicianPro

Phathom Pharmaceuticals, Inc. ·

PHAT 8-K 2026-09-29

Phathom Pharmaceuticals, Inc. (PHAT) 8-K dated 2026-09-29 — accession 0001193125-26-407696.

Phathom Pharmaceuticals, Inc. (PHAT) is a biotechnology company listed on US.

Phathom Pharmaceuticals, Inc. filed a 8-K on 2026-09-29. Accession 0001193125-26-407696.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PHAT revenue for 2025-12-31 was $175.1M. Net income was -$221.2M. Revenue was up 216.9% from 2024-12-31 to 2025-12-31. PHAT currently screens at market cap $622.7M.

Not investment advice. The PHAT SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr